CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI
NCT ID: NCT00162331
Last Updated: 2011-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
74 participants
INTERVENTIONAL
2005-01-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease
NCT00413647
Assessment of Translesional Markers and Metabolomics
NCT00321139
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
NCT01084239
CCTA and Dynamic CT Perfusion for the Diagnosis of Myocardial Ischemia in Patients With Coronary Stents
NCT04742933
Ischemic Time and Extent of Myocardial Infarction (MI) With Cardiac Magnetic Resonance Imaging (CMRI) in Patients With ST Elevation Myocardial Infarction (STEMI) and Primary Percutaneous Coronary Intervention (PCI) Study
NCT01401881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Technetium Tc99m Sestamibi
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lantheus Medical Imaging
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lantheus Medical Imaging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qi Zhu, MD
Role: STUDY_DIRECTOR
Lantheus Medical Imaging
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution
Birmingham, Alabama, United States
Local Institution
Boston, Massachusetts, United States
Local Institution
Nashville, Tennessee, United States
Local Institution
Seattle, Washington, United States
Local Institution
Curibita, , Brazil
Local Institution
São Paulo, , Brazil
Local Institution
Ottawa, Ontario, Canada
Local Institution
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CARDIOLITE-413
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.